Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
Drew and Davies's trial to assess the effectiveness of
Ginkgo biloba in tinnitus, which was conducted by post and
telephone, raises several important methodological
issues.1 The advantages of such a design are obvious: easy
and quick recruitment of patients allowing large sample sizes at
comparatively low costs. The disadvantages are exemplified by the
study's limitations.1
As there was no doctor-patient contact the exact diagnoses are not
certain, and the outcome measures depict only perceived effects.
External monitoring and quality control were impossible, which means
that the quality and reliability of the rough data are questionable.
The patients' general practitioners could probably not be informed,
and serious adverse events or drug interactions were impossible to
assess. Ginkgo biloba has antiplatelet
activity2 and thus can lead to serious bleeding
for
example, haemorrhagic stroke
and an increase in bleeding tendency when
taken concomitantly with oral anticoagulants.
3 4
The question is whether the
Read all Rapid Responses